دورية أكاديمية
1099P Long-term survival follow-up from the REDUCTOR trial: Neoadjuvant cytoreductive treatment with BRAF/MEK inhibition of prior unresectable regionally advanced melanoma to allow complete surgical resection
| العنوان: | 1099P Long-term survival follow-up from the REDUCTOR trial: Neoadjuvant cytoreductive treatment with BRAF/MEK inhibition of prior unresectable regionally advanced melanoma to allow complete surgical resection |
|---|---|
| المؤلفون: | Burgers, F.H., Blankenstein, S., Rohaan, M., Seijkens, T., Klop, M., van der Hiel, B., Lahaye, M., van de Wiel, B., Sari, A., Van Houdt, W., van Akkooi, A.C.J., Haanen, J.B.A.G. |
| المصدر: | In Annals of Oncology October 2023 34 Supplement 2:S662-S662 |
| قاعدة البيانات: | ScienceDirect |
كن أول من يترك تعليقا!